Pck1 Deficiency Drives Mitochondrial Dysfunction and Cellular Senescence in Adipocytes
Aging Cell · 2026
DOI: 10.1111/acel.70462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Yiting Lei und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, Institute of Aging Research, School of Medical Technology, Guang…. Hauptthemen laut MEDLINE: Mitochondria, Cellular Senescence, Adipocytes, Phosphoenolpyruvate Carboxykinase (GTP). Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cellular senescence of white adipose tissues (WAT) represents an early hallmark of aging; however, the involved mechanisms remain incompletely understood. Here, we identified the cytosolic phosphoenolpyruvate carboxykinase (Pck1) as a key regulator of mitochondrial function and inflammaging in WAT. Pck1 expression was downregulated in both gonadal WAT and inguinal WAT during aging, and adipocyte‐specific Pck1 deficiency accelerated inflammaging and metabolic disorders. Untargeted metabolomic and isotope‐tracing analyses revealed that loss of Pck1 impaired cataplerosis, the export of tricarboxylic acid (TCA) cycle intermediates, resulting in accumulation of fumarate in adipocytes. Supplementation with exogenous fumarate disrupted mitochondrial homeostasis of adipocytes, promoted oxidative stress and triggered cytosolic release of mitochondrial DNA (mtDNA), leading to the activation of the cyclic GMP‐AMP synthase/stimulator of interferon genes (cGAS/STING) signaling pathway that may contribute to inflammaging and chronic obesity. These were phenocopied with Pck1‐deficient adipocytes. Conversely, overexpression of fumarate hydratase (Fh1) reduced fumarate level substantially and attenuated adipocyte inflammaging. Collectively, these findings identify Pck1 as a pivotal regulator of mitochondrial metabolic homeostasis and suggest that targeting Pck1 may represent a promising therapeutic strategy for age‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, Institute of Aging Research, School of Medical Technology, Guangdong Medical University, Dongguan, China.
- School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Förderung
- the National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Lei, Y., Yang, M., Jiang, X., Zhang, Y., Chen, Y., Xie, W., Dai, Q., Qin, W., Deng, X., Zhang, X., Zhou, Z., Huang, G., & Liu, X. (2026). Pck1 Deficiency Drives Mitochondrial Dysfunction and Cellular Senescence in Adipocytes. Aging Cell. https://doi.org/10.1111/acel.70462
Vancouver
Lei Y, Yang M, Jiang X, Zhang Y, Chen Y, Xie W, et al. Pck1 Deficiency Drives Mitochondrial Dysfunction and Cellular Senescence in Adipocytes. Aging Cell. 2026. doi:10.1111/acel.70462
BibTeX
@article{Lei2026,
author = {Lei, Yiting and Yang, Meng and Jiang, Xiaoyun and Zhang, Yujie and Chen, Yuzhi and Xie, Weiheng and Dai, Qihui and Qin, Weihong and Deng, Xiuqin and Zhang, Xiaojun and Zhou, Zhongjun and Huang, Gonghua and Liu, Xinguang},
title = {Pck1 Deficiency Drives Mitochondrial Dysfunction and Cellular Senescence in Adipocytes},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70462}
}
EUVIMED